Overview / Abstract: |
Target Audience Program Overview Join a panel of pulmonology and allergy experts, who will discuss patient cases to illustrate disease and management aspect of asthma with comorbidities. Panelists will review the negative impact of uncontrolled moderate‐to‐severe asthma on airway remodeling and lung development in children. Panelists will also discuss conditions that occur frequently with asthma and their shared pathophysiology as a treatment target. Current evidence, including long‐term data and guideline recommendations for asthma treatment will be explored, along with strategies to develop personalized treatment plans for patients based on asthma phenotype, biomarkers, and comorbidities. Learning Objectives Summarize the negative effects of comorbidities on the disease burden of moderate‐to‐severe asthma and on clinicians’ ability to achieve disease control |
Expiration |
Jul 20, 2024 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
AMA PRA Category 1 Credit™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Theresa Guilbert, MD, MS Anju T. Peters, MD, MSCI Stacey Denham, MSW, MPH |
Sponsors / Supporters / Grant Providers |
Regeneron Pharmaceuticals, Inc. and Sanofi |
Keywords / Search Terms |
Relias LLC Relias LLC, FreeCME, Allergy & Immunology, Pulmonology, Asthma, Lymphoma Free CE CME |